Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the US Ending the HIV Epidemic jurisdictions

被引:29
|
作者
Sullivan, Patrick S. [1 ]
Mouhanna, Farah [2 ,4 ]
Mera, Robertino [3 ]
Pembleton, Elizabeth [1 ]
Castel, Amanda D. [2 ]
Jaggi, Chandni [1 ]
Jones, Jeb [1 ]
Kramer, Michael R. [1 ]
McGuinness, Pema [1 ]
McCallister, Scott [3 ]
Siegler, Aaron J. [4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[2] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol, Washington, DC USA
[3] Gilead Sci, Foster City, CA USA
[4] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA
关键词
HIV prevention; HIV pre-exposure prophylaxis; Pharmacy data; UNITED-STATES; ANTIRETROVIRAL PROPHYLAXIS; MEN; SEX; SURVEILLANCE; PREVENTION; INFECTION; RISK;
D O I
10.1016/j.annepidem.2020.01.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Pre-exposure prophylaxis (PrEP) is a pillar of the US Department of Health and Human Services "Ending the HIV Epidemic" (EHE) initiative in 50 EHE jurisdictions (48 U.S. counties and two U.S. cities) and seven U.S. states with high numbers of HIV diagnoses rates in rural areas. Current data systems do not provide data on PrEP uptake in counties or cities. Methods: We report on PrEP users at the county level. Data from a large, commercial pharmacy database were used; we applied the U.S. Census Bureau's method to allocate PrEP users within a ZIP3 into counties and validated the results. We report counts and rates of PrEP users in 2018 for all EHE jurisdictions. We used joinpoint regression to model the estimated annual percent change in PrEP use for each jurisdiction and state. Results: 93,156 people in the 50 EHE jurisdictions used PrEP in 2018; 94% were men and 39% were aged 25-34 years. There was more than an 80-fold difference in the range of rates of PrEP use per 100,000 population among the EHE jurisdictions (range: 8-644 per 100,000 population; median 93 per 100,000 population). PrEP use increased from 2012 to 2018 in all EHE counties and states. At current rates of growth of PrEP use, 94% of EHE counties and jurisdictions will reach their National HIV/AIDS Strategy goals of a 500% increase in PrEP use in 2020. EHE states had less variation in rates of PrEP use (range: 29 -51/100,000 population; median 32/100,000 population). Conclusions: At the outset of a major U.S. government program to reduce HIV infections, rates of PrEP use are highly variable among the 50 EHE jurisdictions. Data from commercial prescription databases will be a useful public resource to understand progress in promoting use of PrEP as part of the EHE initiative and evaluating progress in PrEP use across health jurisdictions. (C) 2020 The Authors. Published by Elsevier Inc.
引用
收藏
页码:16 / 30
页数:15
相关论文
共 50 条
  • [31] The HIV pre-exposure prophylaxis (PrEP) Impact trial: baseline demographics, coverage and first regimen choice
    Sullivan, Ann
    Desai, Monica
    Saunders, John
    Cartier, Andrea
    Jaffer, Sajjida
    Milinkovic, Ana
    Diamente, Victor
    Hibbert, Matthew
    Mason, Emily
    Mitchell, Holly
    Osman, Roeann
    Chiavenna, Chiara
    Charlett, Andre
    Gold, Deborah
    Gilson, Richard
    Gill, Noel
    HIV MEDICINE, 2021, 22 : 10 - 11
  • [32] High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda
    Ssempijja, Victor
    Nakigozi, Gertrude
    Ssekubugu, Robert
    Kagaayi, Joseph
    Kigozi, Godfrey
    Nalugoda, Fred
    Nantume, Betty
    Batte, James
    Kigozi, Grace
    Yeh, Ping Teresa
    Nakawooya, Hadijja
    Serwadda, David
    Quinn, Thomas C.
    Gray, Ronald H.
    Wawer, Maria J.
    Grabowski, Kate M.
    Chang, Larry W.
    Van't Hoog, Anja
    Cobelens, Frank
    Reynolds, Steven J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2022, 90 (03) : 291 - 299
  • [33] Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence US City
    Scott, Rachel K.
    Hull, Shawnika J.
    Huang, Jim C.
    Ye, Peggy P.
    Lotke, Pamela
    Beverley, Jason
    Moriarty, Patricia
    Balaji, Dhikshitha
    Ward, Allison
    Holiday, Jennifer
    Brant, Ashley R.
    Elion, Rick
    Visconti, Adam J.
    Coleman, Megan
    WOMENS HEALTH ISSUES, 2023, 33 (05) : 541 - 550
  • [34] MINOR CONSENT LAWS AND HIV PRE-EXPOSURE PROPHYLAXIS (PREP) USE AMONG US ADOLESCENTS: A MIXED-METHODS STUDY
    Martin, Erika
    Avila-Acosta, Montserrat
    Valentine, Sheila
    Pepin, Dawn
    Hoover, Karen
    Huang, Ya-lin
    Zhu, Weiming
    Patel, Rupa
    Fodeman, Ari
    Pampati, Sanjana
    JOURNAL OF ADOLESCENT HEALTH, 2025, 76 (03)
  • [35] Clinic-Level Strategies for Mitigating Structural and Interpersonal HIV Pre-Exposure Prophylaxis Stigma
    Price, Devon M.
    Unger, Zoe
    Wu, Yumeng
    Meyers, Kathrine
    Golub, Sarit A.
    AIDS PATIENT CARE AND STDS, 2022, 36 (03) : 115 - 122
  • [36] Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the US: A Narrative Review of the Literature
    Baldwin, Aleta
    Light, Brenda
    Allison, Waridibo E.
    ARCHIVES OF SEXUAL BEHAVIOR, 2021, 50 (04) : 1713 - 1728
  • [37] Baseline demographics, coverage and first regimen choice of participants in the HIV Pre-Exposure Prophylaxis (PrEP) Impact trial
    Sullivan, A.
    Saunders, J.
    Cartier, A.
    Jaffer, S.
    Milinkovic, A.
    Priestley, C.
    Manavi, K.
    Waters, L.
    Mason, E.
    Hibbert, M.
    Chiavenna, C.
    Charlett, A.
    Estcourt, C.
    Sabin, C.
    Rodger, A.
    Gold, D.
    McOwan, A.
    Gill, N.
    Desai, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [38] Out-of-pocket costs and HIV pre-exposure prophylaxis persistence in a US multicity demonstration project
    Furukawa, Nathan W.
    Schneider, John A.
    Coleman, Megan E.
    Wiener, Jeffrey B.
    Shrestha, Ram K.
    Smith, Dawn K.
    HEALTH SERVICES RESEARCH, 2020, 55 (04) : 524 - 530
  • [39] Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand
    Viriyathorn, Shaheda
    Sachdev, Saranya
    Suwanwela, Waraporn
    Wangbanjongkun, Waritta
    Patcharanarumol, Walaiporn
    Tangcharoensathien, Viroj
    HEALTH POLICY AND PLANNING, 2023, 38 : i36 - i48
  • [40] HIV PRE-EXPOSURE PROPHYLAXIS IMPLEMENTATION FOR ADOLESCENTS: PROVIDER PERSPECTIVES OF MULTI-LEVEL BARRIERS AND FACILITATORS
    Johnson, Amy
    Green, Evelyn
    Phillips, Gregory, II
    Macapagal, Kathryn
    Stonehouse, Patrick
    Greene, George
    JOURNAL OF ADOLESCENT HEALTH, 2020, 66 (02) : S129 - S129